In a landmark announcement the FDA has approved a new drug consisting of cannabidiol (CBD), to treat two rare forms of severe childhood-onset epilepsies. CBD is a cannabinoid derived from marijuana and the FDA’s approval of this new medicine will force the DEA to reschedule the compound from its current restricted level…
Continue Reading Historic milestone as first marijuana-derived medicine approved by FDA
Cannabis extract reduces seizures in children with rare form of epilepsy
Australian clinical trial set to study cannabis as insomnia treatment
Cannabinoids shown to enhance tumor-killing effects of chemotherapy drugs
Could legal recreational marijuana help solve the opioid crisis?
Scientists separate medical benefits of THC from “unwanted side effects”
Gut bacteria mechanism behind the anti-seizure effects of ketogenic diet uncovered